MILAN, ITALY — Amplifon reported stronger growth and improved profitability during the second quarter of 2026, with the hearing care company recording its highest organic quarterly growth in two years and reaffirming its outlook for the full year....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate financial update with no direct implications for clinical practice.
Amplifon's acquisition of GN Hearing would create a vertically integrated retail-and-manufacturer giant, reshaping competitive dynamics across audiology dispensing and hearing aid supply chains globally.
- 01Amplifon reported its strongest organic quarterly revenue growth in two years in Q2 2026.
- 02The company reaffirmed its full-year financial outlook, signaling management confidence.
- 03Integration of GN Hearing (maker of ReSound devices) is progressing.
- 04The combined entity would span both hearing aid retail and manufacturing.
- 05Deal completion and integration timeline details were not specified in the report.
Amplifon achieved its highest organic quarterly growth in two years in Q2 2026.
press releasepartially supportedAmplifon reaffirmed its full-year financial outlook following Q2 2026 results.
press releasesupportedAmplifon is making progress toward integrating GN Hearing into its operations.
press releaseunclear
